Skip to main content
Premium Trial:

Request an Annual Quote

Getting In On the Google Money

Google Ventures, formed back in March, has made its first investment into a biotech company, according to Fierce Biotech. The company invested about $13 million into antibody start-up Adimabm, which uses computational approaches to develop its antibody library. Google Venture plans to invest $100 million in biotech in the coming year. "Google Ventures has a pretty broad mandate," managing partner William Maris says to Dow Jones. "We're looking for [companies] that have potential to make a big impact."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.